Macrogenics Inc (MGNX) Stock Price, Quote, News & History

MGNXNASDAQ
$4.14
-0.02-0.48%
At close: May 29, 5:00 PM EST
$4.18
0.0170.41%
Pre-Market: 3:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-69.96M
Investing Cash Flow (TTM)
-78.68M
Financing Cash Flow (TTM)
69.59M
Free Cash Flow (TTM)
-71.69M
Capital Expenditure (TTM)
-1.73M
Net Change in Cash (TTM)
-79.05M

Analyst Trends and Forecast

1
Mar
2
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$145.43M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.67
PB Ratio (TTM)
12.41
Earnings Yield % (TTM)
-26.81%
Earnings Yield % (FWD)
-43.96%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.33

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$66.52M
Debt to Equity
1.72
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$4.14
Volume / Avg.
0 / 1.28M
Day Range
- - -
52 Wk Range
1.19 - 4.64
Market Cap
$265.50M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
7.95%
Days to Cover
2.49

About

Sector
Health Care
Industry
Biotechnology
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conju...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Macrogenics (MGNX) stock?

A

You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Macrogenics (MGNX) competitors?

A

There are no as such competitors for Macrogenics.

Q

What is the forecast, or price target, for Macrogenics (MGNX) stock?

A

Macrogenics has a consensus price target of $7.80.

Q

What is the current price for Macrogenics (MGNX)?

A

The stock price for Macrogenics (NASDAQ: MGNX) is $4.177 last updated June 1, 2026 at 4:17 PM EDT.

Q

Does Macrogenics (MGNX) pay a dividend?

A

There are no upcoming dividends for Macrogenics.

Q

When is Macrogenics (NASDAQ:MGNX) reporting earnings?

A

Macrogenics does not have any upcoming earnings scheduled.

Q

Is Macrogenics (MGNX) going to split?

A

There is no upcoming split for Macrogenics.

Q

What sector and industry does Macrogenics (MGNX) operate in?

A

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.